Seqens Seqens

X

Digital content for Reistone Biopharma

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Reistone Biopharma
China Flag
Country
Country
China
Address
Address
Room 203, 2F, Xiangke Road, Zhangjiang Hi-Tech Park, Pudong,Shanghai, 201210
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://scrip.pharmaintelligence.informa.com/SC146406/Small-Molecules-Attract-Investors-As-Two-Chinese-Biotechs-Bag-$161m

Dexter Yan SCRIP
19 May 2022

https://www.clinicaltrialsarena.com/news/reistone-atopic-dermatitis-trial/

CLINICALTRIALSARENA
12 Oct 2021

https://www.prnewswire.com/news-releases/reistone-announces-positive-results-from-a-phase-ii-study-evaluating-shr0302-ointment-for-patients-with-mild-to-moderate-atopic-dermatitis-301396652.html

PRNEWSWIRE
11 Oct 2021

https://endpts.com/immunocores-bispecific-lands-speedy-review-with-fda-ema-low-profile-gene-therapy-player-grabs-30m/

Paul Schloesser\nMax Gelman\nAmber Tong ENDPTS
24 Aug 2021

https://www.prnewswire.com/news-releases/reistone-announces-positive-topline-phase-2-results-for-shr0302-a-selective-jak1-inhibitor-for-treatment-of-patients-with-alopecia-areata-301360967.html

PRNEWSWIRE
24 Aug 2021

https://www.prnewswire.com/news-releases/reistone-announces-first-patient-dosed-in-phase-iii-global-study-in-atopic-dermatitis-301290192.html

PRNEWSWIRE
13 May 2021

https://www.prnewswire.com/news-releases/positive-phase-2-results-for-reistones-jak-inhibitor-demonstrate-significant-improvement-in-patients-with-moderate-to-severe-ulcerative-colitis-301222353.html

PRNNEWSWIRE
04 Feb 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY